|
Center
for Drug Evaluation &
Research (CDER) News |
Center
for Biologics Evaluation &
Research (CBER) |
Center
for Device &
Radiological
Health (CDRH) |
Federal Register -
Meetings, Notices, & Rule Changes |
November 14, 2008
-
Emerging Viral Infections
(updated)
-
New
and Generic Drug Approvals
-
Anastrozole
Tablets, Natco Pharma Ltd.,
Tentative Approval
-
Cardene
(nicardipine hydrochloride)
Injection, EKR Therapeutics,
Inc., Formulation Revision
-
Combivent
(ipratropium bromide and
albuterol sulfate)
Inhalation Aerosol,
Boehringer Ingelheim
Pharmaceuticals, Inc.,
Labeling Revision
-
Ethyol
(amifostine) Injection,
MedImmune, Labeling Revision
-
Loratadine
Tablets, Mylan
Pharmaceuticals, Inc.,
Approval
-
Premarin
(conjugated estrogens)
Vaginal Cream, Wyeth
Pharmaceuticals Inc., New or
Modified Indication
-
Sutent
(sunitinib malate) Capsules,
Pfizer Inc., Labeling
Revision
-
Warning Letter: SINUS SCIENCE
Aerosol Medication Delivery
System
November 13, 2008
November 13, 2008
November 12, 2008
-
Drugs@FDA Downloadable Data
Files
(updated)
-
Drugs Shortages: Resolved Drug
Shortages; Fentanyl Transdermal
Patch
-
FDA
updates the Early Communication
about the Ongoing Safety Review
of Bisphosphonates.
Information
-
Medical, Statistical, and
Clinical Pharmacology Reviews of
Pediatric Studies
(updated)
-
New
and Generic Drug Approvals
-
Amiodarone Hydrochloride
Tablets, Apotex Corp.,
Approval
-
Clozaril
(clozapine) Tablets,
Novartis Pharmaceuticals
Corp., Labeling Revision
-
Crestor
(rosuvastatin calcium)
Tablets, IPR
Pharmaceuticals, Inc., New
or Modified Indication
-
Dorzolamide Hydrochloride
Ophthalmic Solution, Sandoz
Canada Inc., Approval
-
Dorzolamide Hydrochloride
and Timolol Maleate
Ophthalmic Solution, Sandoz
Canada Inc., Approval
-
Questions and Answers on Current
Good Manufacturing Practices,
Good Guidance Practices, Level 2
Guidance Production and Process
Controls
(updated)
November 10, 2008
-
Ethex Corp and FDA notify
healthcare professionals of a
voluntary recall of five generic
products due to the potential
for oversized tablets.
MedWatch Safety Information
-
New
and Generic Drug Approvals
-
Apriso
(mesalamine)
Extended-Release Capsules,
Salix Pharmaceuticals, Inc.,
Approval
-
Cefazolin
(cefazolin sodium)
Injection, B. Braun Medical,
Inc., Labeling Revision
-
Diethylpropion Hydrochloride
Tablets, CorePharma LLC,
Approval
-
Divalproex Sodium
Delayed-Release Tablets,
Anchen Pharmaceuticals,
Inc., Approval
-
Levetiracetam
Tablets, Mylan
Pharmaceuticals Inc.,
Approval
-
Ranexa
(ranolazine)
Extended-Release Tablets, CV
Therapeutics, New or
Modified Indication
-
Treanda
(bendamustine hydrochloride)
Injection, Cephalon Inc.,
Approval
-
Truvada
(emtricitabine and tenofovir
disoproxil fumarate)
Tablets, Gilead Sciences,
Inc., Labeling Revision
-
Viread
(tenofovir disoproxil
fumarate) Tablets, Gilead
Sciences, Inc., Labeling
Revision
CDER Drug Links
|
|
|
November 14, 2008 |
 |
Summary Information for: ATS
3f Aortic Bioprosthesis
 |
 |
General and Plastic Surgery
Devices Panel Advisory
Meeting, November 18-19,
2008 - Agenda, Roster,
Briefing, Questions, Slides
 |
 |
Summary Information for:
TAXUS Libertι Paclitaxel-Eluting
Coronary Stent System
(Monorail and Over-the-Wire)
 |
|
|
|
November 13, 2008 |
 |
Federal Register:
Anesthesiology and
Respiratory Therapy Devices
Panel of the Medical Devices
Advisory Committee; Notice
of Meeting
  |
 |
Orthopaedic and
Rehabilitation Devices Panel
Advisory Meeting, November
14, 2008, Agenda, Roster,
Briefing, Questions
 |
|
|
|
November 10, 2008 |
 |
Federal Register:
Obstetrical and
Gynecological Devices;
Designation of Special
Controls for Male Condoms
Made of Natural Rubber
Latex.
  |
|
|
Medical Device Links
|
|
This
Week
Rule Changes:
21 CFR Parts 101
-
17
-
884 |
|
Friday,
Nov. 14, 2008 |
NOTICES
Pediatric Advisory
Committee,
6752467525 [E827117]
[TEXT] [PDF]
Pediatric Ethics
Subcommittee,
6752567526 [E827118]
[TEXT] [PDF]
|
|
Thurs.,
Nov. 13, 2008 |
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals; Guidance for
Industry, etc.,
6718467186 [E827008]
[TEXT] [PDF]
Interim Safety and Risk
Assessment of Melamine and
Its Analogues in Food for
Humans; Availability,
6718667187 [E826869]
[TEXT] [PDF]
Meetings:
Anesthesiology and Respiratory Therapy Devices Panel of
the Medical Devices Advisory
Committee,
6718767188 [E826965]
[TEXT] [PDF]
Request for Notification
From Industry Organizations
Interested in Participating
in Selection Process, etc.,
6718867189 [E826963]
[TEXT] [PDF]
|
|
Wed., Nov.
12, 2008 |
RULES
Food Labeling: Health
Claims; Calcium and
Osteoporosis, and Calcium,
Vitamin D, and Osteoporosis,
66754 [E826868]
[TEXT] [PDF]
Maximum Civil Money Penalty
Amounts and Compliance with
the Federal Civil Penalties
Inflation Adjustment Act,
6675066754 [E826866]
[TEXT] [PDF]
PROPOSED RULES
Maximum Civil Money Penalty
Amounts and Compliance with
the Federal Civil Penalties
Inflation Adjustment Act,
6681166815 [E826864]
[TEXT] [PDF]
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals,
6690166906 [E826863]
[TEXT] [PDF]
Approval of Original
Abbreviated New Animal Drug
Application; Phenylbutazone
Tablets,
6690666907 [E826793]
[TEXT] [PDF]
|
|
Tuesday,
Nov. 11, 2008 |
NONE
|
|
Monday,
Nov. 10, 2008 |
|
RULES
Obstetrical and
Gynecological Devices;
Designation of Special
Controls for Male Condoms
Made of Natural Rubber
Latex,
6652266539 [E826825]
[TEXT] [PDF]
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals
Class II Special Controls Guidance Document: Labeling
for Natural Rubber Latex
Condoms (Classified Under 21
CFR 884.5300),
6664566646 [E826828]
[TEXT] [PDF]
Determination of Regulatory
Review Period for Purposes
of Patent Extension; IXEMPRA,
6664666647 [E826678]
[TEXT] [PDF]
6664766648 [E826679]
[TEXT] [PDF]
|
|
|
|
.jpg)


EU - US - ICH GMP
Combination Product
handbook |
|
US GMP Training Booklet |
|
Std. GMPs
- Parts 11, 210, 211, 820 &
ICH Q7 |
|
Med. Device - 11, 50,
54, 56, 807, 812, 814, 820,
510k/PMA |
|
Clinical GCP - Parts 11,
50, 54, 56, 312, 314 & ICH
E2A & E6 |
|
Multi-US GMPs 11, 58,
210/211, 600, 601, 610
& 820 |
|
Parts 210/211 - Drug
GMPs |
|
>210/211
with Part 11 |
|
>210/211
with Part 820 |
|
>210/211
with Parts 820 & 11 |
|
>210/211
w/ Keyword Index |
Part 820
Quality Systems Regs
|
|
Part 58 - GLP Good
Lab. Practice |
Part 11
- Electronic Records w/
Scope and Applications
|
GLP 2 11 & 58 - Part 11
& 58
|
PDMA 11,
203 & 205 - Prescription
Drug Marketing
|
|
|
11
& 820 Electronic Record
and Quality Systems
|
|
|
|
The e-Newsletter of
What's New with CDER, CDRH & CBER
Distributed by the worlds
leader in Federal Regulations,
GMP Publications, Inc. & FDA.COM
Tel: 866-GXPNews (or 856-810-7331) Fax: 856-810-7339
http://www.gmppublications.com /
http://www.fda.com
John Cuspilich, Sr. Editor, GXPNews
If you would
like to advertise in this eNewsletter, call
856-810-1825
|